Genelux (GNLX) Current Assets (2022 - 2026)
Genelux's (GNLX) quarterly Current Assets came in at $26.8 million in Q1 2026, up 76.83% quarter-over-quarter from $15.1 million in Q4 2025.
Genelux (GNLX) Current Assets (2022 - 2026) Analysis & Trends
Genelux's Current Assets history runs 5 years deep, the most recent figure standing at $26.8 million for Q1 2026.
- On a quarterly basis, Current Assets changed N/A year-over-year to $26.8 million in Q1 2026; TTM through Mar 2026 was $26.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $15.1 million, down 52.04% from the prior year.
- Current Assets rose to $26.8 million in Q1 2026 per GNLX's latest filing, from $15.1 million in the prior quarter.
- Across five years, Current Assets topped out at $36.0 million in Q3 2024 and bottomed at $1.9 million in Q4 2022.
- The 5-year median for Current Assets is $26.8 million (2026), against an average of $24.9 million.
- Across the five-year window, Current Assets soared 1179.23% in 2023 and tumbled 52.04% in 2025, its largest moves.
- Year by year, Current Assets stood at $1.9 million in 2022, then surged by 1179.23% to $24.2 million in 2023, then soared by 30.35% to $31.5 million in 2024, then tumbled by 52.04% to $15.1 million in 2025, then jumped by 76.83% to $26.8 million in 2026.
- Per Business Quant, the three latest GNLX Current Assets figures stand at $26.8 million (Q1 2026), $15.1 million (Q4 2025), and $21.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 73.04 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 3.59 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 6.60 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.97 Bn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 26.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.75 Mn |
| Dec 31, 2025 | 15.13 Mn |
| Sep 30, 2025 | 21.55 Mn |
| Jun 30, 2025 | 29.24 Mn |
| Dec 31, 2024 | 31.55 Mn |
| Sep 30, 2024 | 35.97 Mn |
| Jun 30, 2024 | 34.87 Mn |
| Mar 31, 2024 | 21.20 Mn |
| Dec 31, 2023 | 24.20 Mn |
| Sep 30, 2023 | 31.18 Mn |
| Dec 31, 2022 | 1.89 Mn |